PROSTATIC CANCER
Clinical trials for PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could reveal hidden prostate cancer
Diagnosis OngoingThis study tests a radioactive tracer called 18F-DCFPyL to see if it can better find prostate cancer that has spread or come back after treatment. About 360 men with high-risk or recurrent prostate cancer will get a PET/CT scan using this tracer. The goal is to improve how doctor…
Matched conditions: PROSTATIC CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 17, 2026 02:00 UTC
-
New imaging agent could sharpen detection of metastatic prostate cancer
Diagnosis OngoingThis study tests whether a new radioactive tracer called 18F-DCFPyL can better detect where prostate cancer has spread in the body compared to a standard tracer. About 96 adults with metastatic prostate cancer will receive both types of scans and be followed for one year. The goa…
Matched conditions: PROSTATIC CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 17, 2026 01:59 UTC